Precision BioPharma
Precision BioPharma is a drug development organization focused on rapid development of small-molecule therapeutics using an adaptive translational research approach and AI/ML-assisted research processes. The organization emphasizes medicinal chemistry, preclinical pipeline development (antiviral, anti-inflammatory, anti-thrombotic candidates), formulation development and clinical trial strategy including regulatory and IND pathways.
Industries
Nr. of Employees
small (1-50)
Precision BioPharma
Belmont, California, United States, North America
Products
Small-molecule candidate for COVID-19 (PB-004)
A small-molecule compound in development described as having potential utility in treating COVID-19.
Repurposed therapeutic planned for Phase 2B (PB-200)
An FDA-approved drug repurposed and planned for Phase 2B trials to address COVID-19-induced pneumonia.
Small-molecule candidate for COVID-19 (PB-004)
A small-molecule compound in development described as having potential utility in treating COVID-19.
Repurposed therapeutic planned for Phase 2B (PB-200)
An FDA-approved drug repurposed and planned for Phase 2B trials to address COVID-19-induced pneumonia.
Services
Drug discovery and preclinical development
Small-molecule discovery and progression through preclinical candidate identification using medicinal chemistry and AI-assisted workflows.
Clinical trial strategy and operational support
Design and planning support for clinical trials including strategy for Phase II studies.
Regulatory consulting and IND support
Regulatory strategy services to support IND submissions and interactions with global regulatory authorities.
Formulation development and repurposing support
Development of novel formulations and assessment of approved drugs for repurposing in new indications.
Drug discovery and preclinical development
Small-molecule discovery and progression through preclinical candidate identification using medicinal chemistry and AI-assisted workflows.
Clinical trial strategy and operational support
Design and planning support for clinical trials including strategy for Phase II studies.
Regulatory consulting and IND support
Regulatory strategy services to support IND submissions and interactions with global regulatory authorities.
Formulation development and repurposing support
Development of novel formulations and assessment of approved drugs for repurposing in new indications.
Expertise Areas
- Clinical trial management and strategy
- Medicinal chemistry and lead optimization
- Preclinical drug development
- Regulatory strategy and IND submissions
Key Technologies
- Adaptive translational research
- Machine learning / AI for research
- Medicinal chemistry
- Drug repurposing methodologies